During the past decade, MeritCare Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MeritCare Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 2 trials, followed by "Baim Institute for Clinical Research" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MeritCare Hospital" #1 collaborator was "Medtronic" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cordis Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "MeritCare Hospital" are "Adenocarcinoma of the Colon" (1 trials), "Coronary Artery Disease" (1 trials), "Heart Failure, Congestive" (1 trials), "Iliac Artery Stenosis" (1 trials) and "Known CAD, or Intermediate-high Pretest Likelihood for CAD" (1 trials). Many other conditions were trialed in "MeritCare Hospital" in a lesser frequency.

Most popular intervention types in "MeritCare Hospital" are "Drug" (5 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anti-coagulation therapy" (1 trials), "Anti-platelet therapy" (1 trials), "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials), "Epic™ Nitinol Stent System" (1 trials) and "Locally Directed Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "MeritCare Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "MeritCare Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in MeritCare Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MeritCare Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".